Status:
UNKNOWN
Identification of a Pool of miRNA to Improve Early Management of Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy
Lead Sponsor:
Ospedale Buon Consiglio Fatebenefratelli
Collaborating Sponsors:
Federico II University
Conditions:
Hypoxic-Ischemic Encephalopathy
Asphyxia Perinatal
Eligibility:
All Genders
35-42 years
Brief Summary
Hypoxic-ischemic encephalopathy is the most common cause of neurological damage in the neonatal period. It has an incidence of about 1.5-2.5% of livebirths in developed countries. It is associated wit...
Detailed Description
Hypoxic-ischemic encephalopathy is the most common cause of neurological damage in the neonatal period. It has an incidence of about 1.5-2.5% of livebirths in developed countries. It is associated wit...
Eligibility Criteria
Inclusion
- newborns with at least 35 weeks of gestational age
- body weight of at least 1800 g
Exclusion
- Withdrawal of informed consent
Key Trial Info
Start Date :
July 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 18 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05986994
Start Date
July 18 2023
End Date
July 18 2024
Last Update
August 14 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neuroscience, Reproductive and Dentistry Sciences, University of Naples Federico II
Naples, Italy, 80131
2
Department of Woman and Child, Buon Consiglio Fatebenefratelli Hospital
Napoli, Italy, 80123